Jaffetilchin Investment Partners LLC Has $427,000 Position in CIGNA Co. (CI)

Jaffetilchin Investment Partners LLC reduced its stake in CIGNA Co. (NYSE:CI) by 25.1% in the 4th quarter, Holdings Channel reports. The firm owned 2,104 shares of the health services provider’s stock after selling 704 shares during the period. Jaffetilchin Investment Partners LLC’s holdings in CIGNA were worth $427,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Northwestern Mutual Wealth Management Co. lifted its holdings in CIGNA by 2.3% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,760 shares of the health services provider’s stock worth $295,000 after purchasing an additional 40 shares during the last quarter. Veritable L.P. lifted its holdings in shares of CIGNA by 0.5% during the second quarter. Veritable L.P. now owns 8,220 shares of the health services provider’s stock worth $1,376,000 after buying an additional 41 shares during the last quarter. MML Investors Services LLC lifted its holdings in shares of CIGNA by 0.8% during the second quarter. MML Investors Services LLC now owns 5,774 shares of the health services provider’s stock worth $967,000 after buying an additional 43 shares during the last quarter. Argent Capital Management LLC lifted its holdings in shares of CIGNA by 2.0% during the second quarter. Argent Capital Management LLC now owns 2,613 shares of the health services provider’s stock worth $437,000 after buying an additional 50 shares during the last quarter. Finally, Eqis Capital Management Inc. lifted its holdings in shares of CIGNA by 3.1% during the third quarter. Eqis Capital Management Inc. now owns 8,949 shares of the health services provider’s stock worth $1,673,000 after buying an additional 267 shares during the last quarter. Hedge funds and other institutional investors own 87.74% of the company’s stock.

Shares of CIGNA Co. (CI) opened at $210.89 on Friday. CIGNA Co. has a 1 year low of $133.52 and a 1 year high of $212.46. The firm has a market capitalization of $51,990.00, a price-to-earnings ratio of 23.10, a price-to-earnings-growth ratio of 1.44 and a beta of 0.51. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.39 and a quick ratio of 0.39.

CIGNA (NYSE:CI) last announced its quarterly earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share for the quarter, beating analysts’ consensus estimates of $2.36 by $0.47. CIGNA had a return on equity of 18.85% and a net margin of 5.74%. The firm had revenue of $10.38 billion for the quarter, compared to analysts’ expectations of $10.17 billion. During the same period in the prior year, the business posted $1.94 earnings per share. The business’s revenue was up 5.1% compared to the same quarter last year. equities research analysts anticipate that CIGNA Co. will post 10.34 EPS for the current fiscal year.

A number of brokerages have recently commented on CI. Morgan Stanley upped their price target on CIGNA from $195.00 to $223.00 and gave the stock an “overweight” rating in a report on Friday, November 3rd. Royal Bank of Canada reiterated an “outperform” rating and set a $220.00 price target (up from $185.00) on shares of CIGNA in a report on Friday, November 3rd. Goldman Sachs Group began coverage on CIGNA in a report on Wednesday, January 3rd. They set a “neutral” rating and a $247.00 price target for the company. Jefferies Group upped their price target on CIGNA from $201.00 to $221.00 and gave the stock a “buy” rating in a report on Friday, October 13th. Finally, Credit Suisse Group began coverage on CIGNA in a report on Thursday, November 2nd. They set an “outperform” rating and a $219.00 price target for the company. Three equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. CIGNA presently has an average rating of “Buy” and a consensus price target of $205.18.

In other news, insider Michael W. Triplett sold 10,417 shares of the stock in a transaction on Monday, November 13th. The stock was sold at an average price of $197.77, for a total transaction of $2,060,170.09. Following the sale, the insider now owns 32,347 shares in the company, valued at $6,397,266.19. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Alan Muney sold 15,345 shares of the stock in a transaction on Monday, November 27th. The stock was sold at an average price of $200.80, for a total value of $3,081,276.00. Following the sale, the executive vice president now owns 28,457 shares in the company, valued at approximately $5,714,165.60. The disclosure for this sale can be found here. Insiders sold 34,936 shares of company stock worth $6,979,204 over the last quarter. Company insiders own 1.30% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Jaffetilchin Investment Partners LLC Has $427,000 Position in CIGNA Co. (CI)” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://www.com-unik.info/2018/01/12/jaffetilchin-investment-partners-llc-has-427000-position-in-cigna-co-ci.html.

About CIGNA

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit